Drug Trial Radar · NCT05279313
A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
Last checked: Nov 20, 2026Latest source record: May 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
680
Actual
Start
Feb 24, 2022
Primary completion
Apr 24, 2026
Study completion Apr 24, 2026
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Mar 15, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate long-term safety exposure
Conditions
- Attention Deficit/Hyperactivity Disorder
Interventions
Centanafadine HydrochlorideDrug
Capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency and severity of treatment-emergent adverse events (TEAEs) will be assessed to determine long-term safety and tolerability of Centanafadine QD XR Capsules.Time frame: Minimum duration of 52 weeks, up to a maximum of approximately 136 weeks or early termination.
Locations
86 sites in 3 countries. Site status is shown where the registry gives one.
Harmonex Neuroscience Research
Dothan, Alabama
The Center for Clinical Trials, Inc.
Saraland, Alabama
Southwest Autism Research and Resource Center
Phoenix, Arizona
Preferred Research Partners, Inc.
Little Rock, Arkansas
Woodland International Research Group
Little Rock, Arkansas
Care Access
Beverly Hills, California
Proscience Research Group
Culver City, California
Sun Valley Research Center, Inc.
Imperial, California
Long Beach Clinical Trials Services, Inc
Long Beach, California
NRC Research Institute
Orange, California
SDS Clinical Trials Inc
Santa Ana, California
CMB Clinical Trials
Santee, California
Pacific Clinical Research Management Group LLC
Upland, California
MCB Clinical Research Centers
Colorado Springs, Colorado
Mindscapes Counseling LLC DBA Comprehensive Psychiatric Care, PC
Norwich, Connecticut
Sarkis Clinical Trials
Gainesville, Florida
Direct Helpers Research Center
Hialeah, Florida
Reliable Clinical Research, LLC
Hialeah, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
West Broward Outpatient Site
Lauderhill, Florida
Accel Research Sites - Maitland
Maitland, Florida
Columbus Clinical Services, LLC
Miami, Florida
Clinical Trials Solution
Miami, Florida
Care Research Inc
Miami, Florida
Acevedo Clinical Research Associates
Miami, Florida
ABRI
Miami, Florida
Ivetmar Medical Group, LLC
Miami, Florida
Miami Clinical Research
Miami, Florida
Florida International Research Center
Miami, Florida
Anchor Medical Research, LLC
Miami, Florida
RM Medical Research, Inc.
Miami Lakes, Florida
Medical Research Group of Central Florida
Orange City, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Apg Research, Llc
Orlando, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Space Coast Neuropsychiatric Research Institute
Palm Bay, Florida
University of South Florida, Psychiatry and Behavioral Neurosciences
Tampa, Florida
Neuroscience Research Institute
West Palm Beach, Florida
Atlanta Behavioral Research, LLC
Atlanta, Georgia
CenExcel-iResearch, LLC
Decatur, Georgia
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.